Targeted Modulation of HER Receptor Signaling in Breast Cancer Using miR-21.

被引：0
|
作者：
Aubele, M. [1 ]
Ludyga, N. [1 ]
Braselmann, H. [1 ]
Atkinson, M. J. [1 ]
Auer, G. [1 ]
Anastasov, N. [1 ]
机构：
[1] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P3-03-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-03-04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Modulation of miR-21 signaling by MPS1 in human glioblastoma
    Maachani, Uday B.
    Tandle, Anita
    Shankavaram, Uma
    Kramp, Tamalee
    Camphausen, Kevin
    ONCOTARGET, 2016, 7 (33) : 52912 - 52927
  • [32] Modulation of MiR-21 signaling by MPS1 in human glioblastoma
    Maachani, Uday Bhanu
    Tandle, Anita
    Shankavaram, Uma
    Kramp, Tamalee
    Camphausen, Kevin A.
    CANCER RESEARCH, 2015, 75
  • [33] Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer
    Zhang, Xi
    Harbeck, Nadia
    Jeschke, Udo
    Doisneau-Sixou, Sophie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1107 - 1122
  • [34] HER2 signaling regulates Fn14 receptor expression in breast cancer cells
    Asrani, Kaushal V.
    Winkles, Jeffrey A.
    CANCER RESEARCH, 2010, 70
  • [35] Aryl hydrocarbon receptor agonists inhibit EGFR/HER4 signaling in breast cancer cells
    Yamashita, Naoya
    Kanno, Yuichiro
    Kizu, Ryoichi
    CANCER SCIENCE, 2022, 113 : 1536 - 1536
  • [36] Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer
    Xi Zhang
    Nadia Harbeck
    Udo Jeschke
    Sophie Doisneau-Sixou
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1107 - 1122
  • [37] Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer
    Andrahennadi, Samitha
    Sami, Amer
    Manna, Mita
    Pauls, Mehrnoosh
    Ahmed, Shahid
    CURRENT ONCOLOGY, 2021, 28 (03) : 1803 - 1822
  • [38] Breast cancer organoids model treatment response of HER2 targeted therapy in HER2-mutant breast cancer
    Li, X.
    Pan, B.
    Ma, J.
    Zhao, Z.
    Li, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.
    Murata, Takeshi
    Takahashi, Maiko
    Hayashida, Tetsu
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [40] Revisiting Androgen Receptor Signaling in Breast Cancer
    Dai, Charles
    Ellisen, Leif W.
    ONCOLOGIST, 2023, 28 (05): : 383 - 391
12345